Literature DB >> 9421308

Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release.

J L Kadurugamuwa1, T J Beveridge.   

Abstract

Pseudomonas aeruginosa (and various other gram-negative pathogens) liberate membrane vesicles during normal growth. These bilayered vesicles consist of endotoxin (lipopolysaccharide), outer membrane proteins and several potent hydrolytic enzymes including protease, alkaline phosphatase, phospholipase C and peptidoglycan hydrolase. The vesicles contain pro-elastase and alkaline phosphatase (which are periplasmic constituents) and so are important for packaging periplasmic components as they are liberated to the outside of the cell. Once liberated, the vesicles are capable of fusing with the membranes of epithelial cells and liberating their virulence factors into host cells where they degrade cellular components, thereby aiding infection by the pathogen. The aminoglycoside antibiotic, gentamicin, is thought to kill bacteria by inhibiting protein synthesis, yet this cationic antibiotic can also perturb the packing order of lipids, thereby destabilizing bilayered membranes. For pathogens with highly anionic lipopolysaccharide on their surface, such as P. aeruginosa, this membrane destabilization can be so serious that it can cause cell lysis; these cells are therefore killed by a combination of protein synthesis inhibition and surface perturbation. By destabilizing the membranes of P. aeruginosa, gentamicin increases the release of membrane vesicles three- to five-fold. This may help account for some of the bacterium-mediated toxicity encountered during patient treatment with aminoglycoside antibiotics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421308     DOI: 10.1093/jac/40.5.615

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  73 in total

Review 1.  Structures of gram-negative cell walls and their derived membrane vesicles.

Authors:  T J Beveridge
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

Review 2.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 3.  Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life.

Authors:  Brooke L Deatherage; Brad T Cookson
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

4.  Synthetic effect between envelope stress and lack of outer membrane vesicle production in Escherichia coli.

Authors:  Carmen Schwechheimer; Meta J Kuehn
Journal:  J Bacteriol       Date:  2013-07-12       Impact factor: 3.490

5.  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Authors:  Athanasios Chatzimoschou; Maria Simitsopoulou; Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

6.  Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria.

Authors:  Z Li; A J Clarke; T J Beveridge
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

7.  Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Epoxide-mediated CifR repression of cif gene expression utilizes two binding sites in Pseudomonas aeruginosa.

Authors:  Alicia E Ballok; Christopher D Bahl; Emily L Dolben; Allia K Lindsay; Jessica D St Laurent; Deborah A Hogan; Dean R Madden; George A O'Toole
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

Review 9.  Functional advantages conferred by extracellular prokaryotic membrane vesicles.

Authors:  Andrew J Manning; Meta J Kuehn
Journal:  J Mol Microbiol Biotechnol       Date:  2013-04-18

10.  Envelope control of outer membrane vesicle production in Gram-negative bacteria.

Authors:  Carmen Schwechheimer; Claretta J Sullivan; Meta J Kuehn
Journal:  Biochemistry       Date:  2013-04-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.